Next Article in Journal
Clinical Significance of the Neutrophil–Lymphocyte Ratio as an Early Predictive Marker for Adverse Outcomes in Patients with Acute Cholangitis
Previous Article in Journal
Towards an Accurate Estimation of COVID-19 Cases in Kazakhstan: Back-Casting and Capture–Recapture Approaches
Previous Article in Special Issue
COPD in Firefighters: A Specific Event-Related Condition Rather than a Common Occupational Respiratory Disorder
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD

School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202, USA
*
Author to whom correspondence should be addressed.
Medicina 2022, 58(2), 254; https://doi.org/10.3390/medicina58020254
Submission received: 4 December 2021 / Revised: 30 January 2022 / Accepted: 1 February 2022 / Published: 8 February 2022

Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) may lead to a rapid decline in health and subsequent death, an unfortunate tyranny of having COPD—an irreversible health condition of 16 million individuals in the USA totaling 60 million in the world. While COPD is the third largest leading cause of death, causing 3.23 million deaths worldwide in 2019 (according to the WHO), most patients with COPD do not receive adequate treatment at the end stages of life. Although death is inevitable, the trajectory towards end-of-life is less predictable in severe COPD. Thus, clinician-patient discussion for end-of-life and palliative care could bring a meaningful life-prospective to patients with advanced COPD. Here, we summarized the current understanding and treatment of COPD. This review also highlights the importance of patient-centered discussion and summarizes current status of managing patients with advanced COPD.
Keywords: chronic bronchitis; chronic obstructive pulmonary disease; spirometry; exacerbation; bronchodilators; end-of-life care; palliative care; global initiative for chronic obstructive lung disease; β2-agonists; corticosteroids; dyspnea; emphysema chronic bronchitis; chronic obstructive pulmonary disease; spirometry; exacerbation; bronchodilators; end-of-life care; palliative care; global initiative for chronic obstructive lung disease; β2-agonists; corticosteroids; dyspnea; emphysema

Share and Cite

MDPI and ACS Style

Mitzel, H.; Brown, D.; Thomas, M.; Curl, B.; Wild, M.; Kelsch, A.; Muskrat, J.; Hossain, A.; Ryan, K.; Babalola, O.; et al. Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD. Medicina 2022, 58, 254. https://doi.org/10.3390/medicina58020254

AMA Style

Mitzel H, Brown D, Thomas M, Curl B, Wild M, Kelsch A, Muskrat J, Hossain A, Ryan K, Babalola O, et al. Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD. Medicina. 2022; 58(2):254. https://doi.org/10.3390/medicina58020254

Chicago/Turabian Style

Mitzel, Holly, Dakota Brown, Morgan Thomas, Byrne Curl, Mackenzie Wild, Andrea Kelsch, Judge Muskrat, Abulquasem Hossain, Ken Ryan, Olawale Babalola, and et al. 2022. "Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD" Medicina 58, no. 2: 254. https://doi.org/10.3390/medicina58020254

APA Style

Mitzel, H., Brown, D., Thomas, M., Curl, B., Wild, M., Kelsch, A., Muskrat, J., Hossain, A., Ryan, K., Babalola, O., Burgard, M., & Mehedi, M. (2022). Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD. Medicina, 58(2), 254. https://doi.org/10.3390/medicina58020254

Article Metrics

Back to TopTop